BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9164971)

  • 1. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
    Haas C; Ryffel B; Le Hir M
    J Immunol; 1997 Jun; 158(11):5484-91. PubMed ID: 9164971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
    Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
    J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F; Di Marco R; Zaccone P; Xiang M; Magro G; Grasso S; Morrone S; Santoni A; Shoenfeld Y; Garotta G; Meroni P
    Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
    Haas C; Ryffel B; Le Hir M
    J Immunol; 1998 Apr; 160(8):3713-8. PubMed ID: 9558072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis.
    Takahashi S; Nose M; Sasaki J; Yamamoto T; Kyogoku M
    J Immunol; 1991 Jul; 147(2):515-9. PubMed ID: 2071894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
    Reilly CM; Olgun S; Goodwin D; Gogal RM; Santo A; Romesburg JW; Ahmed SA; Gilkeson GS
    Eur J Immunol; 2006 May; 36(5):1296-308. PubMed ID: 16541466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
    Gyotoku Y; Abdelmoula M; Spertini F; Izui S; Lambert PH
    J Immunol; 1987 Jun; 138(11):3785-92. PubMed ID: 3495570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
    J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
    Klinman DM
    J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
    Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
    J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.